IMPDH2-targeted Constraint of Cell Growth in Hepatocellular Carcinoma by Mycophenolic Acid

被引:0
|
作者
Chen, Kan [1 ,2 ]
Man, Kwan [3 ]
Metselaar, Herold J. [1 ]
Janssen, Harry L. A. [1 ,4 ]
Kwekkeboom, Jaap [1 ]
Sprengers, Dave [1 ]
Bruno, Marco J. [1 ]
Peppelenbosch, Maikel P. [1 ]
Pan, Qiuwei [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Zhejiang Sci Tech Univ, Coll Life Sci, Bio X Ctr, Hangzhou, Zhejiang, Peoples R China
[3] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hlth Network, Div Gastroenterol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-340
引用
收藏
页码:S256 / S256
页数:1
相关论文
共 50 条
  • [41] Ursolic acid modulates T Cell compartment of hepatocellular carcinoma
    Lopez, Patricia L. Da Costa
    Cortes, Andrea C.
    Minamiguchi, Kyiouki
    Williams, Malea L.
    Dupuis, Crystal J.
    Anfossi, Simone
    Melancon, Marites P.
    Avritscher, Rony
    CANCER RESEARCH, 2023, 83 (07)
  • [42] Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
    Meng-Na Wu
    Wen-Jie Zheng
    Wen-Xin Ye
    Li Wang
    Ying Chen
    Jie Yang
    Deng-Fu Yao
    Min Yao
    World Journal of Gastroenterology, 2021, 27 (23) : 3327 - 3341
  • [43] Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
    Wu, Meng-Na
    Zheng, Wen-Jie
    Ye, Wen-Xin
    Li Wang
    Chen, Ying
    Yang, Jie
    Yao, Deng-Fu
    Yao, Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (23) : 3327 - 3341
  • [44] Targeted arsenite-loaded nanoparticles effectively inhibit the growth and metastasis of hepatocellular carcinoma
    Chi, X.
    Li, H.
    Yin, Z.
    Zhao, Z.
    Zhang, Z.
    Zhang, S.
    Zhao, W.
    Zhou, J.
    Wang, X.
    Gao, J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (3-4) : 222 - 222
  • [45] Secretory Clusteriri as a Novel Molectilar-targeted Therapy for Inhibiting Hepatocellular Carcinoma Growth
    Yao, Min
    Sai, Wenli
    Zheng, Wenjie
    Wang, Li
    Dong, Zhizhen
    Yao, Dengfu
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (20) : 3290 - 3301
  • [46] Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma
    Liu, Yue
    Hinnant, Benjamin
    Chen, Shang
    Tao, Hongyan
    Huang, Ziyu
    Qian, Meng
    Zhou, Manqian
    Han, Zhibo
    Han, Zhong-Chao
    Zhang, Jun
    Li, Zongjin
    EXPERIMENTAL CELL RESEARCH, 2024, 443 (02)
  • [47] Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma
    Zhang, Heng
    Jiang, Yu
    Ni, XiaoLing
    Chen, LongXia
    Wu, Min
    Liu, Jing
    Yang, Bo
    Shan, Xu
    Yang, LingLin
    Fan, Juan
    Chen, Yue
    Wu, JingBo
    Fu, ShaoZhi
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2018, 14 (01) : 114 - 126
  • [48] GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma
    Li, Luhao
    Li, Suxin
    Wang, Haohao
    Li, Lin
    Wang, Peiju
    Shen, Dongqi
    Dang, Xiaowei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 625 : 109 - 115
  • [49] Zoledronic acid inhibits growth of hepatocellular carcinoma cells in vitro and in vivo
    LIU Quan
    TAO Yong-hui
    BAI Rui-zhen
    CHANG Shu-jian
    HUA Dong
    中华医学杂志(英文版), 2013, (08) : 1486 - 1490
  • [50] miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma
    Liao, Zhi-bin
    Tan, Xiao-long
    Dong, Ke-shuai
    Zhang, Hong-wei
    Chen, Xiao-ping
    Chu, Liang
    Zhang, Bi-xiang
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 703 - 711